Suchergebnisse - "Chubb, Barrie"

PubPharm (56)

1

The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK

enthalten in: The European journal of health economics : HEPAC : health economics in prevention and care | 2023

von Viljoen, A. | Chubb, B. | Malkin, S. | +3

2

Once-weekly semaglutide versus insulin aspart for the treatment of type 2 diabetes in the UK : A long-term cost-effectiveness analysis based on SUSTAIN 11

enthalten in: Diabetes, obesity & metabolism | 2023

von Evans, M. | Chubb, B. | Malkin, S. | +3

3

An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal-Bolus Insulin in Type 2 Diabetes

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2023

von Lingvay, I. | Catarig, A. | Lawson, J. | +3

4

Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide

enthalten in: Journal of medical economics | 2023

von Berry, S. | Chubb, B. | Acs, A. | +5

5

An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes

enthalten in: Diabetes therapy | 2022

von Lingvay, I. | Catarig, A. | Lawson, J. | +3

6

An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes

enthalten in: Diabetes therapy | 2022

von Lingvay, I. | Catarig, A. | Lawson, J. | +3

7

An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes

enthalten in: Diabetes therapy | 2022

von Lingvay, I. | Catarig, A. | Lawson, J. | +3

8

The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK

enthalten in: The European journal of health economics | 2022

von Viljoen, A. | Chubb, B. | Malkin, S. | +3

9

The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK

enthalten in: The European journal of health economics | 2022

von Viljoen, A. | Chubb, B. | Malkin, S. | +3

10

Preference for Type 2 Diabetes Therapies in the United States : A Discrete Choice Experiment

enthalten in: Advances in therapy | 2022

von Shubrook, J. | Radin, M. | Ali, S. | +5

1
2
3
4
5
6
Nächster »
[6]